Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,458.80    14.20 (0.98%)
Bid:
1,458.60
Ask:
1,459.00
Spread: 0.40 (0.027%)
Market Cap: £120.90b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Total Voting Rights

2 Mar 2026 16:30

RNS Number : 9757U
Rolls-Royce Holdings plc
02 March 2026
 

2 March 2026 

Rolls-Royce Holdings plc

 

Voting Rights and Capital

 

In accordance with DTR 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules (DTR), Rolls-Royce Holdings plc (the Company) notifies the market that as at 28 February 2026, the issued share capital of the Company consisted of:

 

· 8,427,836,621 Ordinary Shares of 20p each.

· 1 Special Rights non-voting share of £1 with no voting rights.

· 21,017,796,103 non-cumulative redeemable preference shares of 0.1p each (C Shares) with no voting rights except at any general meeting at which a resolution to wind up the Company is to be considered in which case the holders of C Shares shall have the right to attend the general meeting and shall be entitled to speak and vote only on such resolution.

 

No shares are held in Treasury.

 

Therefore, the total number of voting rights in the Company is 8,427,836,621 and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Matthew Conacher, Corporate Governance Director

 

governanceteam@rolls-royce.com

 

Rolls-Royce Holdings plc LEI: 213800EC7997ZBLZJH69

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREADDAESLKEFA
Date   Source Headline
1st Aug 20247:00 amRNS2024 Half Year Results
9th Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:00 amRNSTotal Voting Rights
25th Jun 20242:01 pmRNSAdmission of Shares
11th Jun 202411:00 amRNSDirector/PDMR Shareholding
30th May 202410:30 amRNSDirector/PDMR Shareholding
28th May 20243:00 pmRNSDirector/PDMR Shareholding
28th May 202411:00 amRNSDirector/PDMR Shareholding
23rd May 20244:06 pmRNSNotice of Results
23rd May 20247:00 amRNSAGM Statement and Trading Update
8th May 20244:05 pmRNSDirector/PDMR Shareholding
3rd May 20249:57 amRNSHolding(s) in Company
2nd May 20244:24 pmRNSHolding(s) in Company - Amendment
2nd May 202411:34 amRNSHolding(s) in Company
1st May 20243:26 pmRNSHolding(s) in Company
26th Apr 20241:36 pmRNSDirector/PDMR Shareholding
10th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20241:50 pmRNSHolding(s) in Company
2nd Apr 202410:00 amRNSDirector/PDMR Shareholding
26th Mar 202411:00 amRNSDirector/PDMR Shareholding
13th Mar 20249:00 amRNSDirector/PDMR Shareholding
8th Mar 20241:45 pmRNSDirector/PDMR Shareholding
6th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 202411:30 amRNSDirector/PDMR Shareholding
29th Feb 20249:00 amRNSAGM Statement
28th Feb 20243:30 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:30 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSFull Year Results 2023
8th Feb 20244:00 pmRNSDirector/PDMR Shareholding
26th Jan 20243:00 pmRNSDirector/PDMR Shareholding
10th Jan 202411:45 amRNSDirector/PDMR Shareholding
21st Dec 20232:00 pmRNSDirector/PDMR Shareholding
21st Dec 20231:58 pmRNSDirector/PDMR Shareholding
20th Dec 202310:00 amRNSHolding(s) in Company
11th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 202312:00 pmRNSDirector/PDMR Shareholding
1st Dec 20234:00 pmRNSTotal Voting Rights
1st Dec 20233:50 pmRNSDirector/PDMR Shareholding
1st Dec 20233:45 pmRNSDirector/PDMR Shareholding
29th Nov 20232:15 pmRNSDirector/PDMR Shareholding
29th Nov 20231:00 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSCapital Markets Day
8th Nov 202311:30 amRNSDirector/PDMR Shareholding
30th Oct 202310:15 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSRolls-Royce creates more efficient organisation
11th Oct 20232:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20239:30 amRNSHolding(s) in Company
28th Sep 202310:30 amRNSDirector/PDMR Shareholding
11th Sep 20239:30 amRNSDirector/PDMR Shareholding
25th Aug 20232:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.